These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 37299413)

  • 21. The indications and results of the use of teduglutide in patients with short bowel.
    El Khatib M; Billiauws L; Joly F
    Curr Opin Clin Nutr Metab Care; 2023 Sep; 26(5):449-454. PubMed ID: 37421385
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term teduglutide associated with improved response in pediatric short bowel syndrome-associated intestinal failure.
    Wales PW; Hill S; Robinson I; Raphael BP; Matthews C; Cohran V; Carter B; Venick R; Kocoshis S
    J Pediatr Gastroenterol Nutr; 2024 Aug; 79(2):290-300. PubMed ID: 38873891
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Teduglutide for the treatment of short bowel syndrome - a safety evaluation.
    Kochar B; Herfarth HH
    Expert Opin Drug Saf; 2018 Jul; 17(7):733-739. PubMed ID: 29848084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of Teduglutide on Diarrhea in Pediatric Patients with Short Bowel Syndrome-Associated Intestinal Failure.
    Fifi A; Raphael BP; Terreri B; Uddin S; Kaufman SS
    J Pediatr Gastroenterol Nutr; 2023 Nov; 77(5):666-671. PubMed ID: 37889619
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
    Jeppesen PB; Gilroy R; Pertkiewicz M; Allard JP; Messing B; O'Keefe SJ
    Gut; 2011 Jul; 60(7):902-14. PubMed ID: 21317170
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Candidacy of adult patients with short bowel syndrome for treatment with glucagon-like peptide-2 analogues: A systematic analysis of a single centre cohort.
    Pironi L; Sasdelli AS; Venerito FM; Musio A; Pazzeschi C; Guidetti M
    Clin Nutr; 2021 Jun; 40(6):4065-4074. PubMed ID: 33637328
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Teduglutide in short bowel syndrome patients: A way back to normal life?
    Harpain F; Schlager L; Hütterer E; Dawoud C; Kirchnawy S; Stift J; Krotka P; Stift A
    JPEN J Parenter Enteral Nutr; 2022 Feb; 46(2):300-309. PubMed ID: 34614239
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
    Jeppesen PB; Pertkiewicz M; Messing B; Iyer K; Seidner DL; O'keefe SJ; Forbes A; Heinze H; Joelsson B
    Gastroenterology; 2012 Dec; 143(6):1473-1481.e3. PubMed ID: 22982184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved Outcomes Associated With Teduglutide Use in Patients With Both Short Bowel Syndrome and Crohn's Disease.
    Siu RK; Karime C; Hashash JG; Kinnucan J; Picco MF; Farraye FA
    Crohns Colitis 360; 2024 Jan; 6(1):otae007. PubMed ID: 38352117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Single-Center Experience with the Use of Teduglutide in Adult Patients with Short Bowel Syndrome.
    Lam K; Schwartz L; Batisti J; Iyer KR
    JPEN J Parenter Enteral Nutr; 2018 Jan; 42(1):225-230. PubMed ID: 29505151
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Safety and Efficacy of Teduglutide in Pediatric Patients With Intestinal Failure due to Short Bowel Syndrome: A 24-Week, Phase III Study.
    Kocoshis SA; Merritt RJ; Hill S; Protheroe S; Carter BA; Horslen S; Hu S; Kaufman SS; Mercer DF; Pakarinen MP; Venick RS; Wales PW; Grimm AA
    JPEN J Parenter Enteral Nutr; 2020 May; 44(4):621-631. PubMed ID: 31495952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Baseline Characteristics of Adult Patients Treated and Never Treated with Teduglutide in a Multinational Short Bowel Syndrome and Intestinal Failure Registry.
    Gondolesi GE; Pape UF; Mason JB; Allard JP; Pironi L; Casas MNV; Schwartz LK; Joly F; Gabriel A; Sabrdaran S; Zhang P; Kohl-Sobania M; Huang YW; Jeppesen PB
    Nutrients; 2024 Aug; 16(15):. PubMed ID: 39125394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Management of Short Bowel Syndrome With Chronic Intestinal Failure: A Single-Center Experience in Portugal.
    Santos MD; Magalhães V; Loureiro L; Pina P; Castro A; Aguiar P; Rocha A
    Cureus; 2024 Jun; 16(6):e63443. PubMed ID: 39077232
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost-effectiveness of teduglutide in adult patients with short bowel syndrome - a European socioeconomic perspective.
    Walter E; Dawoud C; Hütterer E; Stift A; Harpain F
    Am J Clin Nutr; 2024 May; 119(5):1187-1199. PubMed ID: 38431119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety Findings in Pediatric Patients During Long-Term Treatment With Teduglutide for Short-Bowel Syndrome-Associated Intestinal Failure: Pooled Analysis of 4 Clinical Studies.
    Hill S; Carter BA; Cohran V; Horslen S; Kaufman SS; Kocoshis SA; Mercer DF; Merritt RJ; Pakarinen MP; Protheroe S; Thompson JF; Vanderpool CPB; Venick RS; Wales PW; Smith SE; Yoon M; Grimm AA
    JPEN J Parenter Enteral Nutr; 2021 Sep; 45(7):1456-1465. PubMed ID: 33305440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacologic options for intestinal rehabilitation in patients with short bowel syndrome.
    Jeppesen PB
    JPEN J Parenter Enteral Nutr; 2014 May; 38(1 Suppl):45S-52S. PubMed ID: 24615689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictors and timing of response to teduglutide in patients with short bowel syndrome dependent on parenteral support.
    Chen K; Joly F; Mu F; Kelkar SS; Olivier C; Xie J; Seidner DL
    Clin Nutr ESPEN; 2021 Jun; 43():420-427. PubMed ID: 34024550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-Term Outcomes With Teduglutide From a Single Center.
    Puello F; Wall E; Herlitz J; Lozano ES; Semrad C; Micic D
    JPEN J Parenter Enteral Nutr; 2021 Feb; 45(2):318-322. PubMed ID: 32391948
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
    Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
    Clin Nutr; 2020 Aug; 39(8):2479-2486. PubMed ID: 31784300
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in Parenteral Nutrition Requirements and BMI in Patients with Parenteral Nutrition-Dependent Short Bowel Syndrome after Stopping Teduglutide-9 Years of Follow-Up.
    Zaczek Z; Jurczak-Kobus P; Panczyk M; Braszczyńska-Sochacka J; Majewska K; Kunecki M; Dąbrowska K; Sobocki J
    Nutrients; 2022 Apr; 14(8):. PubMed ID: 35458196
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.